Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001567619-22-017561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-16 | 2022-09-14 | TXG | Wilbur James | Chief Commercial Off | A - Grant | $0.00 | +95.8K | 95.8K | New | $0 |
| D | 2022-09-16 | 2022-09-14 | TXG | Wilbur James | Chief Commercial Off | A - Grant | $0.00 | +239.6K | 239.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-09-14 | A | A | 95,839 | $0.00 | 95,839 | D | — | — | (F1) Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 25% of the RSUs vest on the one-year anniversary measured from August 21, 2022, and 1/16th of the RSUs vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 2 | Derivative | Stock Option (right to buy) | 2022-09-14 | A | A | 239,596 | $0.00 | 239,596 | D | $33.67 · — to 2032-09-14 | 239,596 Class A Common Stock | (F2) 25% of the shares subject to the option vest on the one-year anniversary measured from July 27, 2022, and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person continuing as a service provider through each such date. |